Regulatory MiR-148a-ACVR1/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma-Reference-Cited by-同舟云学术

Regulatory MiR-148a-ACVR1/BMP circuit defines a cancer stem cell-like aggressive subtype of hepatocellular carcinoma

Published:2015-01-20 Issue:2 Volume:61 Page:574-584
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Li Lian¹,Liu Yuexin²,Guo Yan¹,Liu Ben¹,Zhao Yanrui¹,Li Pei¹,Song Fengju¹,Zheng Hong¹,Yu Jingpu³⁴,Song Tianqiang⁵,Niu Ruifang⁶,Li Qiang⁵,Wang Xin Wei⁷,Zhang Wei²,Chen Kexin¹

Affiliation:

1. Department of Epidemiology and Biostatistics, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin; Tianjin Medical University Cancer Institute and Hospital; Tianjin P.R. China

2. Department of Pathology; University of Texas MD Anderson Cancer Center; Houston TX USA

3. Department of Immunology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin; Tianjin Medical University Cancer Institute and Hospital; Tianjin P.R. China

4. TMUCIH-J&J Joint Laboratory; Tianjin Medical University Cancer Institute and Hospital; Tianjin P.R. China

5. Department of Liver Cancer, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin; Tianjin Medical University Cancer Institute and Hospital; Tianjin P.R. China

6. Public Laboratory, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin; Tianjin Medical University Cancer Institute and Hospital; Tianjin P.R. China

7. Laboratory of Human Carcinogenesis; Center for Cancer Research, National Cancer Institute, National Institutes of Health; Bethesda MD USA

Publisher

Wiley

Subject

Hepatology

Reference49 articles.

1. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008;Ferlay;Int J Cancer,2010

2. Liver cancer incidence and mortality in China, 2009;Chen;Chin J Cancer,2013

3. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials;Llovet;Hepatology,1999

4. Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma;Hoshida;Cancer Res,2009

5. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets;Boyault;Hepatology,2007

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNAs in Hepatocellular Carcinoma Pathogenesis: Insights into Mechanisms and Therapeutic Opportunities;International Journal of Molecular Sciences;2024-08-29

2. Inhibition of YAP/TAZ pathway contributes to the cytotoxicity of silibinin in MCF-7 and MDA-MB-231 human breast cancer cells;Cellular Signalling;2024-07

3. Sponging of five tumour suppressor miRNAs by lncRNA-KCNQ1OT1 activates BMPR1A/BMPR1B-ACVR2A/ACVR2B signalling and promotes chemoresistance in hepatocellular carcinoma;Cell Death Discovery;2024-06-08

4. Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma;Drug Resistance Updates;2024-05

5. Cancer stem cells: The important role of CD markers, Signaling pathways, and MicroRNAs;Pathology - Research and Practice;2024-04